Research and Markets (http://www.researchandmarkets.com/research/t5fwx3/infectious) has announced the addition of the "Infectious Disease Testing Market in the US 2015-2019" report to their offering.

This market report forecasts the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

Questions Answered:

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter Diagnostics
  • Roche
  • Siemens Healthcare
  • Abaxis
  • Acon Laboratories
  • Avioq
  • BD
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • EMD Millipore
  • Epitope Diagnostic
  • Gold Standard Diagnostics
  • Hologic
  • Immunetics
  • InBios International
  • Life Technologies
  • Maxim Biomedical
  • Mindray
  • OraSure Technologies
  • Ortho Clinical Diagnostics
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Geographical segmentation

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

PART 15: Key recommendations for vendors/investors

PART 16: Appendix

For more information visit http://www.researchandmarkets.com/research/t5fwx3/infectious